ESPA_EN

The BioCoStent project was co‐financed by the European Union and Greek national funds through the Operational Program Competitiveness, Entrepreneurship and Innovation, under the call RESEARCH – CREATE – INNOVATE (project code:Τ1EDK-03965)

Principal Investigator and coordinator of the project: Anargyros N. Moulas, Ph.D., professor, University of Thessaly.

BioCoStent

Development and study of a coronary stent system using biodegradable biomaterials for targeted and controlled release of an innovative drug

GOAL

Development and study of a coronary stent system using

biodegradable biomaterials for targeted and controlled release of an innovative drug. The stent design…
MORE

TECHNOLOGY

The coronary stent consists of a metal

scaffold made of Cobalt/Chromium alloy coated with biodegradable polymer and retinoic acid…
MORE

CHEMISTRY

Retinoic acid (RA) is a derivative of retinol (vitamin A).

It is a natural component of the human body but is also used as an active medicinal ingredient…
MORE

STRUCTURE

The project is organized into six Work Units (WUs).

WU1: Development of DrugElutingStent (technology using apatented drug.

In WU1, the necessary technologies for DES with retinoic acid and laboratory tests of the prototypes are being developed…

MORE

IMPLEMENTATION

The project is implemented according to a specific schedule

Due to the SARS-CoV-2 pandemic, the program was extended by one year compared to the original plan.
MORE

BioCoStent PROJECT PARTNERS

RONTIS_300x400a
IOANNINWN300x400a
IIBEAA300x400a
FEAC300x400a
MEDLAB300x400a
UTH_GR_300x400a